The effect of FLT3 gene expression in senescence and telomere length regulation in AML cells with FLT3-ITD mutation

被引：0
|
作者：
Hong, Jing Siou [1 ]
Yen, Jui Hung [1 ]
Wu, Chia Ling [2 ]
Chen, Pei Yi [1 ,2 ]
机构：
[1] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan
[2] Hualien Tzu Chi Hosp, Ctr Med Genet, Hualien, Taiwan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1071
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [21] Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
    Xu, Dan
    Chen, Yishan
    Yang, Ying
    Yin, Zhao
    Huang, Changfen
    Wang, Qiang
    Jiang, Ling
    Jiang, Xuejie
    Yin, Changxin
    Liu, Qifa
    Yu, Guopan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [22] Allogeneic transplant for FLT3-ITD mutated AML: a focus on FLT3 inhibitors before, during, and after transplant
    Bazarbachi, Abdul Hamid
    Al Hamed, Rama
    Malard, Florent
    Mohty, Mohamad
    Bazarbachi, Ali
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [23] Current Approaches to Transplantation for FLT3-ITD AML
    Bradley D. Hunter
    Yi-Bin Chen
    Current Hematologic Malignancy Reports, 2020, 15 : 1 - 8
  • [24] Current Approaches to Transplantation for FLT3-ITD AML
    Hunter, Bradley D.
    Chen, Yi-Bin
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2020, 15 (01) : 1 - 8
  • [25] Increasing FLT3-ITD length increases expression of bcl-xl in AML.
    Seedhouse, Claire H.
    Pallis, Monica
    Grundy, Martin
    Russell, Nigel
    BLOOD, 2006, 108 (11) : 541A - 541A
  • [26] Identification of Core Gene Signature Associated with Synergism Between ABT-869, a FLT3 Inhibitor and SAHA, a HDAC Inhibitor in AML with FLT3-ITD Mutation
    Zhou, Jianbiao
    Bi, Chonglei
    Liu, Shaw-Cheng
    Chng, Wee-Joo
    Tay, Kian-Ghee
    Yu, Hanry
    Glaser, Keith
    Albert, Daniel
    Davidsen, Steven K.
    Chen, Chien-Shing
    BLOOD, 2008, 112 (11) : 572 - 572
  • [27] FLT3-ITD Mutation in MDS Patients Is Associated with Early Transformation to AML
    Sumiyoshi, Ritsu
    Tashiro, Haruko
    Matsuo, Takuji
    Yamamoto, Tadashi
    Oka-Miura, Yoko
    Matsumoto, Kensuke
    Ooi, Jun
    Shirafuji, Naoki
    BLOOD, 2017, 130
  • [28] Characterization of genomic alterations of cytarabine-resistant AML cells with FLT3-ITD mutation
    Yen, J. H.
    Chen, Z. A.
    Lin, L. I.
    Chen, P. Y.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1608 - 1608
  • [29] Influence of FLT3-ITD Mutation and Length on the Treatment Response and Prognosis in Cytogenetically Normal AML Patients
    Jiang, Xuejie
    Yin, Changxin
    Sun, Junya
    Cheng, Jiaying
    Wang, Qiang
    Yu, Guopan
    Jiang, Ling
    Xu, Dan
    Liu, Xiaoli
    Feng, Ru
    Liu, Qifa
    BLOOD, 2018, 132
  • [30] Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML
    H Wu
    C Hu
    A Wang
    E L Weisberg
    W Wang
    C Chen
    Z Zhao
    K Yu
    J Liu
    J Wu
    A Nonami
    L Wang
    B Wang
    R M Stone
    S Liu
    J D Griffin
    J Liu
    Q Liu
    Leukemia, 2016, 30 : 754 - 757
12345